Management Team

Hai Wang


Hai is a seasoned pharmaceutical executive with over 25 years of proven experience in both generic and branded pharmaceutical industry. He has played leadership rule in business development, strategy, corporate management, licensing, operation/supply chain management, sales and marketing in the entire business spectrum from APIs to finished dosage forms. Hai heads up Solco’s business and operations. He is also a senior management team member of Prinston Pharmaceutical Inc. and Huahai US Inc. with responsibility of driving strategic growth for the Company in the finished products.

Prior to joining Solco, Hai was the Senior Vice President in Business Development and Marketing at Prinston Pharmaceutical, Inc. He has also co-founded Huahai US, Inc. and held senior management positions there. Hai began his career as a chemist at Vintage Pharmaceutical. He then worked at Pfizer for eight years in various roles with increasing capacities. Hai holds a Bachelor of Pharmaceutical Science degree from East China University of Science and Technology, a Master of Science degree in Chemistry from East Tennessee State University, and a Master of Business Administration degree from Rensselaer Polytechnic Institute - The Lally School of Management and Technology.

Ronald N. Kaufman

Senior Vice President of Sales

Mr. Kaufman brings to Solco Healthcare U.S. more than 30 years experience in both the branded and generic pharmaceutical industry. His achievements at Ross/Abbott Laboratories, Wyeth Laboratories, McNeil Laboratories (Johnson & Johnson), Rugby Laboratories, and QK Healthcare have been noteworthy. While at Ross/Abbott, Mr. Kaufman received the distinguished "Abbott’s Presidential Award" (recognition to a single employee each year) for saving the corporation from a projected loss of over $40 MM. As National Sales Manager of Wyeth Laboratories, Mr. Kaufman was responsible for the creation and implementation of the company’s first Nutritional Division. The division increased market share by more than four points after the first year. During his tenure at Rugby, sales increased by more than $300 million, due in part to Mr. Kaufman’s intimate involvement with the first U.S. "authorized generic products" (Dyazide and Norinyl). As Vice President of Sales at QK Healthcare, annual sales increased from $200 MM to over $2 billion in seven years.

David M. Ayres

Executive Director of Sales

Mr. Ayres joined Solco Healthcare U.S. in January of 2010. As Director of National Accounts, Mr. Ayres is responsible for sales and account management which encompasses every class of trade in the pharmaceutical industry. Since joining Solco, Mr. Ayres has been instrumental in helping Solco grow from $1MM Gross Sales in 2009 to $50MM+ in 2013. In October of 2013, David was honored to be named the Small Generic Company Trade Representative of the Year by Cardinal Health. Prior to joining Solco, Mr. Ayres spent 16 years with WellPoint Next Rx, one of the largest pharmacy benefit managers in the United States, in various capacities including his most recent position, Director of Pharmacy Procurement and Forecasting. Mr. Ayres was responsible for negotiations and management of corporate contracts for pharmacy purchasing, inclusive of manufacturers, vendors, and wholesalers with annual purchases exceeding 2 billion dollars. This responsibility included over 200 million dollars of annual generic Rx purchasing. Mr. Ayres also negotiated all contracts with almost every generic manufacturer in the Unites States and was personally accountable for supplying the Company with generic launch forecast information. Additionally, his responsibilities included management of all human resource in the Generic Pharmacy Procurement department inclusive of contract purchases and negotiations of non-pharmaceutical vendors in excess of 15 million dollars annually. Mr. Ayres currently holds a Bachelor of Science in Business Administration from the University of Phoenix.

Chris Keith

Senior Vice President, Marketing and Business Development

Chris Keith is Solco Healthcare’s Senior Vice President of Marketing and Business Development. Chris utilizes his 25 years of sales, marketing and business development experience in helping Solco achieve its market share and profitability goals. He continues to be part of the senior management team at Prinston Pharmaceutical with the responsibility of identifying opportunities for the company.

Prior to joining Solco, Chris worked at Prinston Pharmaceutical as Vice President, Marketing and Business Development where he successfully negotiated and closed multiple generic drug development deals and several in-licensing, as well as out-licensing opportunities for Prinston. Prior to Prinston, Chris co-founded Éclat Pharmaceuticals where he served as the company’s Executive Vice President, Sales and Marketing. During his time at Éclat, Chris focused on identifying and commercializing niche brand and generic products including several 505(b)(2) injectables and various liquid narcotic products.

Before Éclat, Chris spent 18 years with ETHEX Corporation. During his time at ETHEX, Chris held various roles but spent the majority of his time leading the marketing team as the Vice President, Marketing. Chris was responsible for directing the overall planning, design and implementation of all marketing, advertising and promotional activities relating to both current and future generic pharmaceutical products. Chris and his team were responsible for launching over 50 products with 87% of ETHEX’s products ranked #1 or #2 in market share position, while increasing net revenues $185.2 million within the last four years of his tenure.

Chris holds a Bachelors of Science in Marketing and Management, as well as a Masters of Business Administration from the University of Missouri St. Louis.